Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002377, UL1TR002377, UL1TR002377, UL1TR002377)
Received: 2 February 2022
Accepted: 31 May 2022
First Online: 4 July 2022
: This study was deemed exempt by the Mayo Clinic Institutional Review Board (#20–009206). Informed consent was obtained from all participants in this study. Participants were notified in the email invitation detailing the study that if they clicked on the link to continue with the survey, they consented to have their anonymous results used for research. All methods were performed in accordance with the Declaration of Helsinki.
: The authors declare that they have no competing interests.